0000899243-23-016380.txt : 20230623 0000899243-23-016380.hdr.sgml : 20230623 20230623165238 ACCESSION NUMBER: 0000899243-23-016380 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230621 FILED AS OF DATE: 20230623 DATE AS OF CHANGE: 20230623 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lazarus Alon CENTRAL INDEX KEY: 0001808244 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40366 FILM NUMBER: 231038462 MAIL ADDRESS: STREET 1: C/O KEROS THERAPEUTICS, INC. STREET 2: 99 HAYDEN AVENUE, SUITE 120, BUILDING E CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Werewolf Therapeutics, Inc. CENTRAL INDEX KEY: 0001785530 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 823523180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 TALCOTT AVENUE STREET 2: 2ND FLOOR CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-952-0555 MAIL ADDRESS: STREET 1: 200 TALCOTT AVENUE STREET 2: 2ND FLOOR CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-21 0 0001785530 Werewolf Therapeutics, Inc. HOWL 0001808244 Lazarus Alon C/O WEREWOLF THERAPEUTICS, INC. 200 TALCOTT AVENUE, 2ND FLOOR WATERTOWN MA 02472 1 0 0 0 0 Stock Option (right to buy) 2.81 2023-06-21 4 A 0 13200 0.00 A 2033-06-20 Common Stock 13200 13200 D The option was granted on June 21, 2023. The shares underlying the option vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders following the grant date, subject to the reporting person's continued service as a director. /s/ Jonathan Owen, Attorney-in-fact 2023-06-23